Furthermore, this study investigated the relationship between RPS6KA2 expression and key signaling pathways associated with cell proliferation (Fig. 1H) and apoptosis (Fig. 1I) in ovarian cancer. This evidence concerns the gene RPS6KA2 and ovarian carcinoma.